首页 / 院系成果 / 成果详情页

Effectiveness of pharmacist intervention in the management of coronary artery disease after index percutaneous coronary intervention: a single center randomized controlled trial 期刊论文

编号：

77aca805-1c82-439f-a742-0a658942702d
作者：

Xu, Nongzhang(许弄章)#^[1,2]Wang, Cuihong#^[2]Wan, Jianwei(万建伟)^[2]Liu, Xiaoqing(刘晓庆)^[2]Li, Zhongdong*^[1]Chen, Min(陈敏)*^[2]
语种：

英文
期刊：

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE ISSN：1940-5901 2019 年 12 卷 6 期 (7760 - 7765)
收录：
关键词：

Coronary artery disease percutaneous coronary intervention pharmaceutical care medication adherence
摘要：

Objective: This study aimed to explore the effect of pharmacist intervention on medication adherence, risk factor control, 6 months prognosis, and 2 years prognosis in patients with coronary artery disease (CAD) after the index percutaneous coronary intervention (PCI). Methods: From January 2015 to December 2015, 200 CAD patients were treated with PCI at our hospital. The control group was given routine treatment and nursing care. In addition to routine treatment and nursing care, the intervention group was given direct pharmacist intervention including medication program optimization, formulated pharmaceutical care, medication education, health education, and outpatient follow-up. The two groups were followed for two years. Readmission rate, incidence of major adverse cardiac events (MACE), readmission expense, awareness rate of secondary prevention drugs, medication adherence, and emotion management were compared between the two groups at 6 months and 2 years after the index procedure. Risk factors in the two groups at 2 years were compared. Results: At 2 years, the risk factors in the intervention group were significantly improved in comparison with the control group [smoking: 3.1% vs. 12.6%, P = 0.012; normal blood glucose rate: 79.6% vs. 62.1%, P = 0.007; normal blood pressure rate: 74.5% vs. 53.7%, P = 0.003; normal blood lipid rate: 84.7% vs. 57.9%, P < 0.001]. The readmission rate, MACE incidence, and readmission expense in the intervention group were significantly lower than the control group at 6 months and 2 years [47.7% vs. 72.6%, P = 0.001; 17.3% vs. 28.8%, P < 0.001; 7512.5 +/- 10269.6 RMB vs. 22172.6 +/- 24413.2 RMB, P= 0.025]. Conclusion: Pharmacist intervention can effectively improve medication adherence, reduce postoperative risk factors, MACE incidence, medical expenses in patients after the index PCI. These beneficial effects were increasingly more significant along with time.
推荐引用方式
GB/T 7714：

Xu Nongzhang,Wang Cuihong,Wan Jianwei, et al. Effectiveness of pharmacist intervention in the management of coronary artery disease after index percutaneous coronary intervention: a single center randomized controlled trial [J].INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE,2019,12(6):7760-7765.
APA：

Xu Nongzhang,Wang Cuihong,Wan Jianwei,Liu Xiaoqing,&Chen Min.(2019).Effectiveness of pharmacist intervention in the management of coronary artery disease after index percutaneous coronary intervention: a single center randomized controlled trial .INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE,12(6):7760-7765.
MLA：

Xu Nongzhang, et al. "Effectiveness of pharmacist intervention in the management of coronary artery disease after index percutaneous coronary intervention: a single center randomized controlled trial" .INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE 12,6(2019):7760-7765.
条目包含文件：

文件类型：PDF,文件大小：

正在加载全文

未找到全文

浏览次数：68  下载次数：0

分享到：

浏览次数：68

下载次数：0

打印次数：0